DK1587406T3 - Kvantificering af carnitinniveauer hos dialysepatienter - Google Patents

Kvantificering af carnitinniveauer hos dialysepatienter

Info

Publication number
DK1587406T3
DK1587406T3 DK03770386.5T DK03770386T DK1587406T3 DK 1587406 T3 DK1587406 T3 DK 1587406T3 DK 03770386 T DK03770386 T DK 03770386T DK 1587406 T3 DK1587406 T3 DK 1587406T3
Authority
DK
Denmark
Prior art keywords
carnitine
deficiency
methods
diagnosing
quantifying
Prior art date
Application number
DK03770386.5T
Other languages
English (en)
Inventor
Donald H Chace
Gianfranco Fornasini
Original Assignee
Sigma Tau Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Pharmaceuticals Inc filed Critical Sigma Tau Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1587406T3 publication Critical patent/DK1587406T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
DK03770386.5T 2002-09-23 2003-09-23 Kvantificering af carnitinniveauer hos dialysepatienter DK1587406T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/252,115 US7011977B2 (en) 1999-01-30 2002-09-23 Quantification of carnitine levels in dialysis patients
PCT/US2003/029821 WO2004026114A2 (en) 2002-09-23 2003-09-23 Quantification of carnitine levels in dialysis patients

Publications (1)

Publication Number Publication Date
DK1587406T3 true DK1587406T3 (da) 2010-03-15

Family

ID=32029013

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03770386.5T DK1587406T3 (da) 2002-09-23 2003-09-23 Kvantificering af carnitinniveauer hos dialysepatienter

Country Status (11)

Country Link
US (1) US7011977B2 (da)
EP (1) EP1587406B1 (da)
AT (1) ATE449344T1 (da)
AU (1) AU2003278872A1 (da)
CY (1) CY1110607T1 (da)
DE (1) DE60330185D1 (da)
DK (1) DK1587406T3 (da)
ES (1) ES2336787T3 (da)
PT (1) PT1587406E (da)
SI (1) SI1587406T1 (da)
WO (1) WO2004026114A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
US7333894B2 (en) * 2002-01-31 2008-02-19 Sigma-Tau Pharmaceuticals, Inc. Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients
EP1862797A4 (en) * 2005-03-16 2009-09-16 Ajinomoto Kk DEVICE, METHOD, SYSTEM AND PROGRAM FOR EVALUATING BIOLOGICAL STATES, DEVICE, METHOD AND PROGRAM FOR GENERATING AN EVALUATION FUNCTION AND RECORDING MEDIUM
WO2016013115A1 (ja) * 2014-07-25 2016-01-28 株式会社 リージャー 希釈生体試料成分の分析方法
GB201916046D0 (en) * 2019-11-04 2019-12-18 Amazentis Sa Diagnostic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5316917A (en) * 1992-11-04 1994-05-31 Duke University Automated analysis of free l-carnitine and total short-chain acylcarnitine
US6455321B1 (en) * 1999-01-30 2002-09-24 Neo Gen Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US6258605B1 (en) * 1999-03-26 2001-07-10 Neo Gen Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US6335369B1 (en) * 2000-01-19 2002-01-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US6429230B1 (en) * 2000-01-19 2002-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis

Also Published As

Publication number Publication date
WO2004026114A2 (en) 2004-04-01
PT1587406E (pt) 2010-02-23
AU2003278872A1 (en) 2004-04-08
ES2336787T3 (es) 2010-04-16
ATE449344T1 (de) 2009-12-15
AU2003278872A8 (en) 2004-04-08
CY1110607T1 (el) 2015-04-29
DE60330185D1 (de) 2009-12-31
SI1587406T1 (sl) 2010-03-31
US7011977B2 (en) 2006-03-14
EP1587406A4 (en) 2007-01-03
WO2004026114A3 (en) 2004-08-19
EP1587406B1 (en) 2009-11-18
US20030129762A1 (en) 2003-07-10
EP1587406A2 (en) 2005-10-26

Similar Documents

Publication Publication Date Title
EP2319941A3 (en) Method and apparatus for correlating levels of biomarker products with disease
TW200736606A (en) Gated voltammetry
WO2007062225A3 (en) Test substrate handling apparatus
BR112017021305A2 (pt) dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva
EP1978361A3 (en) Method for performing correction of blood glucose assay bias using blood hemoglobin concentration as determined by a glucose-hemoglobin A1C combination system and devices for same
CY1110607T1 (el) Ποσοτικοποιηση επιπεδων καρνιτινης σε ασθενεις που υποβαλλονται σε αιμοκαθαρση
ES2349107T8 (es) Método analítico e instrumento.
WO2008014132A3 (en) Combination analyte measurement device and method of use
AU2003213594A1 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE246356T1 (de) Vorrichtung zum vorhersagen von physiologischen messwerten
UA103474C2 (ru) Устройство для мониторинга места доступа к сосудистой системе и оборудование для экстракорпорального лечения крови с устройством для мониторинга места доступа к сосудистой системе
WO2006006871A3 (en) Method and system for monitoring ventilations
WO2008097773A8 (en) Methods and devices for diagnosis of appendicitis
WO2017070114A3 (en) Diabetes-related biomarkers and treatment of diabetes-related conditions
WO2008040990A3 (en) Methods for determining an analyte concentration using signal processing algorithms
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
MX2022001817A (es) Metodos para detectar isoformas de la region de union a microtubulos (mtbr) tau y uso de las mismas.
DE502005010516D1 (de) Analytisches System und Verfahren zu dessen Betrieb
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN
CA2510377A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2006124917A3 (en) Verification apparatus and methods for optical inspection machine
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
WO2008145701A9 (en) Method for predicting the outcome of a critically ill patient